Works matching DE "VENETOCLAX"

Results: 495

Oral Therapies for Multiple Myeloma.
Published in:
touchREVIEWS in Oncology & Haematology, 2022, v. 18, n. 2, p. 139, doi. 10.17925/OHR.2022.18.2.139
By:
- Singhal, Sachi;
- Kumar, Shaji
Publication type:
Article
维奈克拉联合阿扎胞苷对老年急性髓系白血病患者 T 淋巴细胞亚群的影响及其疗效的影响因素分析.
Published in:
Progress in Modern Biomedicine, 2024, v. 24, n. 22, p. 4389, doi. 10.13241/j.cnki.pmb.2024.22.057
By:
- 邹娟;
- 冯梦菁;
- 王文静;
- 晁瑶;
- 郑转珍
Publication type:
Article
Comparison of regimens targeting complete remission in the first-line treatment of acute myeloid leukemia patients.
Published in:
European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 21, p. 4493
By:
- YAVUZ, S.;
- MALKAN, U. Y.
Publication type:
Article
The efficacy and safety of venetoclax combined with demethylating agents in elderly patients with acute myeloid leukemia: a systematic review and meta-analysis.
Published in:
European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 5, p. 1837
By:
- WEI, M.-Y.;
- YIN, J.;
- LIAO, Y.;
- LIU, J.-Y.;
- ZHAO, Y.;
- CHEN, X.-M.;
- LIU, Y.;
- WANG, X.-M.;
- HUANG, C.-L.
Publication type:
Article
Real world results of venetoclax combined with hypomethylating agents in relapsed/refractory AML.
Published in:
European Review for Medical & Pharmacological Sciences, 2021, v. 25, n. 21, p. 6557
By:
- UCAR, M. A.;
- OZET, G.;
- KOYUNCU, M. B.;
- SONMEZ, M.;
- AKIDAN, O.;
- AYLI, M.;
- YILDIRIM, M.;
- PEHLIVAN, M.;
- AKKURT, D. M.;
- SAHIN, H.;
- GUVENC, B.;
- OKAN, V.;
- TIFTIK, E. N.;
- AKDENIZ, A.;
- DINCYUREK, H. D.;
- GUNES, A. K.;
- DAGDAS, S.;
- ACAR, H. Ä°.;
- UCAR, H. K.;
- TOMBAK, A.
Publication type:
Article
Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1260003
By:
- Woo, Timothy;
- Carter, Matthew;
- Follows, George;
- Patten, Piers E. M.
Publication type:
Article
Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1193874
By:
- Baohang Zhang;
- Qingguo Liu;
- Junfan Li;
- Yimin Hu;
- Xin Zhao;
- Pingping Huang;
- Shangzhu Li;
- Ying Wang
Publication type:
Article
Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1108994
By:
- Lovato, Ester;
- Gangemi, Concetta;
- Krampera, Mauro;
- Visco, Carlo;
- Ferrarini, Isacco
Publication type:
Article
Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1137175
By:
- Zhangjie Chen;
- Sisi Zhen;
- Tingting Zhang;
- Yuyan Shen;
- Aiming Pang;
- Donglin Yang;
- Rongli Zhang;
- Qiaoling Ma;
- Yi He;
- Jialin Wei;
- Weihua Zhai;
- Xin Chen;
- Erlie Jiang;
- Mingzhe Han;
- Sizhou Feng
Publication type:
Article
Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1149298
By:
- Sciumè, Mariarita;
- Bosi, Alessandro;
- Canzi, Marta;
- Ceparano, Giusy;
- Serpenti, Fabio;
- De Roberto, Pasquale;
- Fabris, Sonia;
- Tagliaferri, Elena;
- Cavallaro, Francesca;
- Onida, Francesco;
- Fracchiolla, Nicola Stefano
Publication type:
Article
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Published in:
Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1143881
By:
- Martinez, Valeria J. Sarapura;
- Buonincontro, Brenda;
- Cassarino, Chiara;
- Bernatowiez, Juliana;
- Colado, Ana;
- Cordini, Gregorio;
- Custidiano, Maria del Rosario;
- Mahuad, Carolina;
- Pavlovsky, Miguel A.;
- Bezares, Raimundo F.;
- Favale, Nicolás O.;
- Vermeulen, Mónica;
- Borge, Mercedes;
- Giordano, Mirta;
- Gamberale, Romina
Publication type:
Article
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
By:
- Al-Sawaf, Othman;
- Zhang, Can;
- Jin, Hyun Yong;
- Robrecht, Sandra;
- Choi, Yoonha;
- Balasubramanian, Sandhya;
- Kotak, Alex;
- Chang, Yi Meng;
- Fink, Anna Maria;
- Tausch, Eugen;
- Schneider, Christof;
- Ritgen, Matthias;
- Kreuzer, Karl-Anton;
- Chyla, Brenda;
- Paulson, Joe;
- Pallasch, Christian P.;
- Frenzel, Lukas P.;
- Peifer, Martin;
- Eichhorst, Barbara;
- Stilgenbauer, Stephan
Publication type:
Article
Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Published in:
2022
By:
- Deng, Yexuan;
- Diepstraten, Sarah T.;
- Potts, Margaret A.;
- Giner, Göknur;
- Trezise, Stephanie;
- Ng, Ashley P.;
- Healey, Gerry;
- Kane, Serena R.;
- Cooray, Amali;
- Behrens, Kira;
- Heidersbach, Amy;
- Kueh, Andrew J.;
- Pal, Martin;
- Wilcox, Stephen;
- Tai, Lin;
- Alexander, Warren S.;
- Visvader, Jane E.;
- Nutt, Stephen L.;
- Strasser, Andreas;
- Haley, Benjamin
Publication type:
Correction Notice
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32485-9
By:
- Deng, Yexuan;
- Diepstraten, Sarah T.;
- Potts, Margaret A.;
- Giner, Göknur;
- Trezise, Stephanie;
- Ng, Ashley P.;
- Healey, Gerry;
- Kane, Serena R.;
- Cooray, Amali;
- Behrens, Kira;
- Heidersbach, Amy;
- Kueh, Andrew J.;
- Pal, Martin;
- Wilcox, Stephen;
- Tai, Lin;
- Alexander, Warren S.;
- Visvader, Jane E.;
- Nutt, Stephen L.;
- Strasser, Andreas;
- Haley, Benjamin
Publication type:
Article
Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance.
Published in:
Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32485-9
By:
- Deng, Yexuan;
- Diepstraten, Sarah T.;
- Potts, Margaret A.;
- Giner, Göknur;
- Trezise, Stephanie;
- Ng, Ashley P.;
- Healey, Gerry;
- Kane, Serena R.;
- Cooray, Amali;
- Behrens, Kira;
- Heidersbach, Amy;
- Kueh, Andrew J.;
- Pal, Martin;
- Wilcox, Stephen;
- Tai, Lin;
- Alexander, Warren S.;
- Visvader, Jane E.;
- Nutt, Stephen L.;
- Strasser, Andreas;
- Haley, Benjamin
Publication type:
Article
Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
Published in:
2021
By:
- Albiol, Nil;
- Novelli, Silvana;
- Mozos, Anna;
- Pratcorona, Marta;
- Martino, Rodrigo;
- Sierra, Jorge
Publication type:
journal article
Keeping up with venetoclax for leukemic malignancies: key findings, optimal regimens, and clinical considerations.
Published in:
Expert Review of Clinical Pharmacology, 2021, v. 14, n. 12, p. 1497, doi. 10.1080/17512433.2021.2008239
By:
- Siddiqui, Maria;
- Konopleva, Marina
Publication type:
Article
Vitamin K2 sensitizes the efficacy of venetoclax in acute myeloid leukemia by targeting the NOXA-MCL-1 pathway.
Published in:
PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0307662
By:
- Tauchi, Tetsuzo;
- Moriya, Shota;
- Okabe, Seiichi;
- Kazama, Hiromi;
- Miyazawa, Keisuke;
- Takano, Naoharu
Publication type:
Article
Budget impact analysis of venetoclax for the management of acute myeloid leukemia from the perspective of the social security and the private sector in Argentina.
Published in:
PLoS ONE, 2024, v. 19, n. 1, p. 1, doi. 10.1371/journal.pone.0295798
By:
- Palacios, Alfredo;
- Espinola, Natalia;
- Gonzalez, Juan Martin;
- Rojas-Roque, Carlos;
- Rivas, Maria Marta;
- Kanevski, Diego;
- Morisset, Pierre;
- Augustovski, Federico;
- Pichon-Riviere, Andres;
- Bardach, Ariel
Publication type:
Article
SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax.
Published in:
Neoplasma, 2022, v. 69, n. 5, p. 1108, doi. 10.4149/neo_2022_220415N416
By:
- Lu LIU;
- Jing LIU;
- Xiao-Jun LIU;
- Meng-Han LIU;
- Xue-Feng FENG;
- Lin YANG;
- Jian-Min LUO
Publication type:
Article
The incidence of translocation t(11;14) among patients with multiple myeloma in a single clinic.
Published in:
American Journal of Clinical Pathology, 2024, v. 161, n. 1, p. 16, doi. 10.1093/ajcp/aqad103
By:
- Jew, Scott;
- Goldwater, Marissa-Skye;
- Bujarski, Sean;
- Regidor, Bernard;
- Emamy-Sadr, Marsiye;
- Swift, Regina;
- Eades, Benjamin;
- Said, Jonathan;
- Berenson, James R
Publication type:
Article
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 13091, doi. 10.3390/ijms252313091
By:
- Bollino, Dominique;
- Ma, Xinrong;
- Tighe, Kayla M.;
- Casildo, Andrea;
- Richard, Katharina;
- Passaniti, Antonino;
- Carter-Cooper, Brandon;
- Strovel, Erin T.;
- Emadi, Ashkan
Publication type:
Article
Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 12569, doi. 10.3390/ijms252312569
By:
- Veyhe, Sólja Remisdóttir;
- Cédile, Oriane;
- Dahlmann, Sara Kamuk;
- Krejcik, Jakub;
- Abildgaard, Niels;
- Høyer, Thor;
- Møller, Michael Boe;
- Thomassen, Mads;
- Juul-Jensen, Karen;
- Frederiksen, Henrik;
- Dybkær, Karen;
- Hansen, Marcus Høy;
- Nyvold, Charlotte Guldborg
Publication type:
Article
Treatment of Double-Refractory Chronic Lymphocytic Leukemia—An Unmet Clinical Need.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1589, doi. 10.3390/ijms25031589
By:
- Zygmunciak, Przemysław;
- Robak, Tadeusz;
- Puła, Bartosz
Publication type:
Article
Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 3, p. 1421, doi. 10.3390/ijms25031421
By:
- Rodríguez-Medina, Carlos;
- Stuckey, Ruth;
- Bilbao-Sieyro, Cristina;
- Gómez-Casares, María Teresa
Publication type:
Article
Venetoclax and Hypomethylating Agent Combination in Myeloid Malignancies: Mechanisms of Synergy and Challenges of Resistance.
Published in:
International Journal of Molecular Sciences, 2024, v. 25, n. 1, p. 484, doi. 10.3390/ijms25010484
By:
- Mishra, Rahul;
- Zokaei Nikoo, Maedeh;
- Veeraballi, Sindhusha;
- Singh, Abhay
Publication type:
Article
Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16899, doi. 10.3390/ijms242316899
By:
- Lima, Keli;
- Carvalho, Maria Fernanda Lopes;
- Pereira-Martins, Diego Antonio;
- Nogueira, Frederico Lisboa;
- de Miranda, Lívia Bassani Lins;
- Nascimento, Mariane Cristina do;
- Cavaglieri, Rita de Cássia;
- Schuringa, Jan Jacob;
- Machado-Neto, João Agostinho;
- Rego, Eduardo Magalhães
Publication type:
Article
Folate-Appended Hydroxypropyl-β-Cyclodextrin Induces Autophagic Cell Death in Acute Myeloid Leukemia Cells.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16720, doi. 10.3390/ijms242316720
By:
- Kubota, Yasushi;
- Hoshiko, Toshimi;
- Higashi, Taishi;
- Motoyama, Keiichi;
- Okada, Seiji;
- Kimura, Shinya
Publication type:
Article
Recent Updates in Venetoclax Combination Therapies in Pediatric Hematological Malignancies.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16708, doi. 10.3390/ijms242316708
By:
- Leśniak, Maria;
- Lipniarska, Justyna;
- Majka, Patrycja;
- Lejman, Monika;
- Zawitkowska, Joanna
Publication type:
Article
AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15849, doi. 10.3390/ijms242115849
By:
- Milnerowicz, Szymon;
- Maszewska, Julia;
- Skowera, Paulina;
- Stelmach, Magdalena;
- Lejman, Monika
Publication type:
Article
A Leukemic Target with a Thousand Faces: The Mitochondria.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13069, doi. 10.3390/ijms241713069
By:
- Maffeo, Beatrice;
- Panuzzo, Cristina;
- Moraca, Amedeo;
- Cilloni, Daniela
Publication type:
Article
Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.
Published in:
International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5802, doi. 10.3390/ijms24065802
By:
- Kotmayer, Lili;
- László, Tamás;
- Mikala, Gábor;
- Kiss, Richárd;
- Lévay, Luca;
- Hegyi, Lajos László;
- Gróf, Stefánia;
- Nagy, Tibor;
- Barna, Gábor;
- Farkas, Péter;
- Weisinger, Júlia;
- Nagy, Zsolt;
- Balogh, Alexandra;
- Masszi, Tamás;
- Demeter, Judit;
- Sulák, Adrienn;
- Kohl, Zoltán;
- Alizadeh, Hussain;
- Egyed, Miklós;
- Pettendi, Piroska
Publication type:
Article
Rationale for Combining the BCL2 Inhibitor Venetoclax with the PI3K Inhibitor Bimiralisib in the Treatment of IDH2- and FLT3-Mutated Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12587, doi. 10.3390/ijms232012587
By:
- Seipel, Katja;
- Brügger, Yvo;
- Mandhair, Harpreet;
- Bacher, Ulrike;
- Pabst, Thomas
Publication type:
Article
The Emerging Role of Venetoclax-Based Treatments in Acute Lymphoblastic Leukemia.
Published in:
2022
By:
- Aumann, Shlomzion;
- Shaulov, Adir;
- Haran, Arnon;
- Gross Even-Zohar, Noa;
- Vainstein, Vladimir;
- Nachmias, Boaz
Publication type:
Literature Review
Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810468
By:
- Hernández-Silva, David;
- Cantón-Sandoval, Joaquín;
- Martínez-Navarro, Francisco Juan;
- Pérez-Sánchez, Horacio;
- de Oliveira, Sofia;
- Mulero, Victoriano;
- Alcaraz-Pérez, Francisca;
- Cayuela, María Luisa
Publication type:
Article
Arsenic Trioxide and Venetoclax Synergize against AML Progenitors by ROS Induction and Inhibition of Nrf2 Activation.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6568, doi. 10.3390/ijms23126568
By:
- Hoang, Dinh Hoa;
- Buettner, Ralf;
- Valerio, Melissa;
- Ghoda, Lucy;
- Zhang, Bin;
- Kuo, Ya-Huei;
- Rosen, Steven T.;
- Burnett, John;
- Marcucci, Guido;
- Pullarkat, Vinod;
- Nguyen, Le Xuan Truong
Publication type:
Article
Venetoclax Induces Cardiotoxicity through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6260, doi. 10.3390/ijms23116260
By:
- AlAsmari, Abdullah F.;
- Alghamdi, Adel;
- Ali, Nemat;
- Almeaikl, Muath A.;
- Hakami, Hassan M.;
- Alyousef, Meshal K.;
- AlSwayyed, Mohammed;
- Alharbi, Metab;
- Alqahtani, Faleh;
- Alasmari, Fawaz;
- Alsaleh, Nasser
Publication type:
Article
New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy.
Published in:
International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3887, doi. 10.3390/ijms23073887
By:
- Andreozzi, Fabio;
- Massaro, Fulvio;
- Wittnebel, Sebastian;
- Spilleboudt, Chloé;
- Lewalle, Philippe;
- Salaroli, Adriano
Publication type:
Article
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10761, doi. 10.3390/ijms221910761
By:
- Nakamura, Ayano;
- Suzuki, Susumu;
- Kanasugi, Jo;
- Ejiri, Masayuki;
- Hanamura, Ichiro;
- Ueda, Ryuzo;
- Seto, Masao;
- Takami, Akiyoshi
Publication type:
Article
Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 18, p. 10105, doi. 10.3390/ijms221810105
By:
- Cluzeau, Thomas;
- Loschi, Michael;
- Fenaux, Pierre;
- Komrokji, Rami;
- Sallman, David A.
Publication type:
Article
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.
Published in:
International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8092, doi. 10.3390/ijms22158092
By:
- Seipel, Katja;
- Graber, Carolyn;
- Flückiger, Laura;
- Bacher, Ulrike;
- Pabst, Thomas
Publication type:
Article
Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Published in:
BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11259-6
By:
- Du, Yufeng;
- Li, Chunhong;
- Zhao, Zhijia;
- Liu, Yikun;
- Zhang, Chengtao;
- Yan, Jinsong
Publication type:
Article
Venetoclax combined with low dose cytarabine compared to standard of care intensive chemotherapy for the treatment of favourable risk adult acute myeloid leukaemia (VICTOR): Study protocol for an international, open-label, multicentre, molecularly-guided randomised, phase II trial.
Published in:
2022
By:
- Dillon, Richard;
- Maycock, Shanna;
- Jackson, Aimee;
- Fox, Sonia;
- Freeman, Sylvie;
- Craddock, Charles;
- Thomas, Catherine;
- Homer, Emma;
- Leahy, Jane;
- Mamwell, Anna;
- Potter, Nicola;
- Russell, Nigel;
- Wei, Andrew;
- Ommen, Hans Beier;
- Hemmaway, Claire;
- Knapper, Steve;
- Billingham, Lucinda
Publication type:
journal article
Venetoclax Combination Treatment of Acute Myeloid Leukemia in Adolescents and Young Adult Patients.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2046, doi. 10.3390/jcm13072046
By:
- Chatzikalil, Elena;
- Roka, Kleoniki;
- Diamantopoulos, Panagiotis T.;
- Rigatou, Efthymia;
- Avgerinou, Georgia;
- Kattamis, Antonis;
- Solomou, Elena E.
Publication type:
Article
Real-Life Multicenter Experience of Venetoclax in Combination with Hypomethylating Agents in Previously Untreated Adult Patients with Acute Myeloid Leukemia in Greece.
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 584, doi. 10.3390/jcm13020584
By:
- Chatzilygeroudi, Theodora;
- Darmani, Ismini;
- El Gkotmi, Natali;
- Vryttia, Pinelopi;
- Douna, Stavroula;
- Bouchla, Anthi;
- Labropoulou, Vasiliki;
- Kotsopoulou, Maria;
- Symeonidis, Argiris;
- Pagoni, Maria;
- Pappa, Vasiliki;
- Papageorgiou, Sotirios G.
Publication type:
Article
Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?
Published in:
Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 549, doi. 10.3390/jcm13020549
By:
- Rahmé, Ramy;
- Braun, Thorsten
Publication type:
Article
LC-Q-TOF-MS driven identification of potential degradation impurities of venetoclax, mechanistic explanation on degradation pathway and establishment of a quantitative analytical assay method.
Published in:
Journal of Analytical Science & Technology, 2020, v. 11, n. 1, p. 1, doi. 10.1186/s40543-020-00252-4
By:
- Pokar, Dhruvisha;
- Sahu, Amit Kumar;
- Sengupta, Pinaki
Publication type:
Article
Treatment of acute myeloid leukemia with active pulmonary tuberculosis with venetoclax‑based anti‑acute myeloid leukemia regimen combined with an intensive and then individualized anti‑tuberculosis regimen: A report of two cases.
Published in:
Oncology Letters, 2024, v. 28, n. 6, p. N.PAG, doi. 10.3892/ol.2024.14734
By:
- Ji, Lin;
- Yang, Wei;
- Gao, Liu Jie;
- Zhang, Bei Yuan;
- Xu, Ya Qing;
- Xu, Xiao Feng
Publication type:
Article
Efficacy of venetoclax and rituximab in the treatment of concurrent acute myeloid leukemia and untreated chronic lymphocytic leukemia: A case report and literature review.
Published in:
Oncology Letters, 2024, v. 28, n. 2, p. N.PAG, doi. 10.3892/ol.2024.14526
By:
- Chen, Yafang;
- Yuan, Linyu;
- Lu, Xinxiao;
- Wang, Xue;
- Zhang, Qiuqiu;
- Wang, Xiaofang;
- Zhao, Xingli
Publication type:
Article
Low‑dose venetoclax combined with azacitidine in older and frail patients with newly diagnosed acute myeloid leukaemia.
Published in:
Oncology Letters, 2024, v. 27, n. 5, p. N.PAG, doi. 10.3892/ol.2024.14362
By:
- Rong, Chunmeng;
- Yang, Fang;
- Chen, Yalu;
- Wang, Ming;
- Ai, Cheng;
- Luo, Yuqing;
- Gao, Panpan;
- Weng, Yiqin;
- Huang, Xiaguang;
- Gu, Meier;
- Huang, Weiping;
- Xia, Yongming
Publication type:
Article